RNF185
E3 ubiquitin-protein ligase RNF185
Also known as: FLJ38628, RN185_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96GF1
- Gene
- RNF185
- Ensembl
- ENSG00000138942
- Chromosome
- 22
- Canonical length
- 192 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables ubiquitin binding activity; ubiquitin protein ligase activity; and ubiquitin-like protein conjugating enzyme binding activity. Involved in several processes, including positive regulation of ERAD pathway; protein ubiquitination; and proteolysis involved in protein catabolic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
192 residues, UniProt reviewed canonical sequence.
>Q96GF1|RNF185
1 MASKGPSASA SPENSSAGGP SGSSNGAGES GGQDSTFECN ICLDTAKDAV ISLCGHLFCW
61 PCLHQWLETR PNRQVCPVCK AGISRDKVIP LYGRGSTGQQ DPREKTPPRP QGQRPEPENR
121 GGFQGFGFGD GGFQMSFGIG AFPFGIFATA FNINDGRPPP AVPGTPQYVD EQFLSRLFLF
181 VALVIMFWLL IALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF185 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 48 nTPM
- parathyroid gland: 46 nTPM
- liver: 45 nTPM
- prostate: 36 nTPM
- kidney: 34 nTPM
- blood vessel: 34 nTPM
Single-cell type
- neutrophils: 153 nCPM
- prostatic glandular cells: 79 nCPM
- podocytes: 69 nCPM
- choroid plexus epithelial cells: 67 nCPM
- syncytiotrophoblasts: 65 nCPM
- myonuclei: 61 nCPM
Immune cell
- neutrophil: 22 nTPM
- basophil: 17 nTPM
- NK-cell: 17 nTPM
- intermediate monocyte: 16 nTPM
- classical monocyte: 16 nTPM
- total PBMC: 15 nTPM
Brain region
- thalamus: 25 nTPM
- white matter: 24 nTPM
- choroid plexus: 23 nTPM
- hippocampal formation: 23 nTPM
- cerebral cortex: 23 nTPM
- midbrain: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagy
- defense response to virus
- endoplasmic reticulum mannose trimming
- ERAD pathway
- innate immune response
- positive regulation of ERAD pathway
- positive regulation of innate immune response
- positive regulation of type I interferon-mediated signaling pathway
- protein autoubiquitination
- protein K27-linked ubiquitination
- transmembrane transport
- ubiquitin-dependent protein catabolic process
Molecular functions
- protein-containing complex binding
- ubiquitin binding
- ubiquitin protein ligase activity
- ubiquitin-like protein conjugating enzyme binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNF185 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF185 as an antibody target. Whether an autoantibody or antibody against RNF185 could matter depends on whether native RNF185 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF185 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF185 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...